Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReBlast Precision
NCT07131475Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2025
- Primary completion
- Apr 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [11C]PBR-28 in blast injury, sponsored by Massachusetts General Hospital. Started Oct 2025; status: recruiting.
02
Drugs
[11C]PBR-28
03
Conditions
blast injury
Beyond the preview
Go deeper on NCT07131475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07131475.